[{"address1": "1111 Kane Concourse", "address2": "Suite 301", "city": "Bay Harbor Islands", "state": "FL", "zip": "33154", "country": "United States", "phone": "781 652 4500", "website": "https://www.avenuetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alexandra  MacLean M.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 413200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Jin", "age": 32, "title": "Interim CFO, COO & Corporate Secretary", "yearBorn": 1991, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald", "age": 68, "title": "Executive Director", "yearBorn": 1955, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xiaoqin  Lu M.D.", "age": 48, "title": "Consultant", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 1046836, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott A. Reines M.D., Ph.D.", "age": 76, "title": "Interim Chief Medical Officer", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 69120, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Srinivas  Subramanian", "age": 52, "title": "Executive Vice President", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 4.52, "open": 4.38, "dayLow": 4.38, "dayHigh": 5.21, "regularMarketPreviousClose": 4.52, "regularMarketOpen": 4.38, "regularMarketDayLow": 4.38, "regularMarketDayHigh": 5.21, "beta": -0.26, "forwardPE": -0.18054055, "volume": 154100, "regularMarketVolume": 154100, "averageVolume": 33565, "averageVolume10days": 96174, "averageDailyVolume10Day": 96174, "bid": 4.94, "ask": 5.1, "bidSize": 200, "askSize": 200, "marketCap": 2956611, "fiftyTwoWeekLow": 4.38, "fiftyTwoWeekHigh": 93.75, "fiftyDayAverage": 10.84, "twoHundredDayAverage": 30.40825, "currency": "USD", "enterpriseValue": 245606, "floatShares": 520333, "sharesOutstanding": 590142, "sharesShort": 2580, "sharesShortPriorMonth": 4178, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0044, "heldPercentInsiders": 0.11813, "heldPercentInstitutions": 0.02794, "shortRatio": 0.19, "shortPercentOfFloat": 0.0044, "impliedSharesOutstanding": 60782800, "bookValue": 4.635, "priceToBook": 1.0809062, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 0.113, "netIncomeToCommon": -10377000, "trailingEps": -73.5, "forwardEps": -27.75, "lastSplitFactor": "1:75", "lastSplitDate": 1714089600, "52WeekChange": -0.9338614, "SandP52WeekChange": 0.23099434, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ATXI", "underlyingSymbol": "ATXI", "shortName": "Avenue Therapeutics, Inc.", "longName": "Avenue Therapeutics, Inc.", "firstTradeDateEpochUtc": 1498570200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ab3c15b5-e280-3b5c-b842-8e87c6276492", "messageBoardId": "finmb_310815442", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.01, "targetHighPrice": 56.25, "targetLowPrice": 56.25, "targetMeanPrice": 56.25, "targetMedianPrice": 56.25, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1783000, "totalCashPerShare": 3.021, "quickRatio": 1.491, "currentRatio": 1.547, "returnOnAssets": -2.09028, "returnOnEquity": -5.35102, "freeCashflow": -13494500, "operatingCashflow": -9451000, "earningsGrowth": -0.763, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]